Evidence map›Paper›PMID 33916859›Full record

ArticleBiology2021

The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs.

Francesca Posa, Graziana Colaianni, Michele Di Cosola, Manuela Dicarlo, Francesco Gaccione, Silvia Colucci, Maria Grano, Giorgio Mori

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Overview ofBioMed research international · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Francesca PosaDepartment of Clinical and Experimental Medicine, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy.ORCID 0000-0001-8099-3505
Graziana ColaianniDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Michele Di CosolaDepartment of Clinical and Experimental Medicine, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy.
Manuela DicarloDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Francesco GaccioneDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Silvia ColucciDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Human Anatomy and Histology, University of Bari, 70124 Bari, Italy.
Maria GranoDepartment of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.ORCID 0000-0002-7121-5899
Giorgio MoriDepartment of Clinical and Experimental Medicine, University of Foggia, Viale Pinto 1, 71122 Foggia, Italy.ORCID 0000-0001-6731-0247
University of Bari Aldo Moro · ITUniversity of Foggia · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 20098KM9RNRegione Puglia D.G.R. n. 2117 of 21.11.2018.
6 · The paper itself

Abstract

The myokine irisin, well known for its anabolic effect on bone tissue, has been demonstrated to positively act on osteoblastic differentiation processes in vitro. Mesenchymal stem cells (MSCs) have captured great attention in precision medicine and translational research for several decades due to their differentiation capacity, potent immunomodulatory properties, and their ability to be easily cultured and manipulated. Dental bud stem cells (DBSCs) are MSCs, isolated from dental tissues, that can effectively undergo osteoblastic differentiation. In this study, we analyzed, for the first time, the effects of irisin on DBSC osteogenic differentiation in vitro. Our results indicated that DBSCs were responsive to irisin, showed an enhanced expression of osteocalcin (OCN), a late marker of osteoblast differentiation, and displayed a greater mineral matrix deposition. These findings lead to deepening the mechanism of action of this promising molecule, as part of osteoblastogenesis process. Considering the in vivo studies of the effects of irisin on skeleton, irisin could improve bone tissue metabolism in MSC regenerative procedures.

Indexed as

bonedental stem cellsirisinmesenchymal stem cells (MSCs)osteoblastogenesisosteocalcinprecision medicinetranslational research

Identifiers

PMID33916859
PMCPMC8065887
OpenAlexW3147284846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.